Insulin-producing cells derived from cloned human embryo

Image
IANS Washington
Last Updated : Apr 29 2014 | 11:34 AM IST

In a pioneering research involving stem cells, researchers in the US have successfully used a cloning technique to make insulin-producing cells with the DNA of a diabetic woman.

A team led by regenerative medicine specialist Dieter Egli at the New York Stem Cell Foundation Research Institute derived embryonic stem cells from a cloned embryo containing the DNA from a 32-year-old woman with type 1 diabetes.

The researchers also succeeded in differentiating these ES cells into insulin-producing cells - opening a new pathway for treating diabetes by replacing pancreatic cells.

"The new work is a step toward providing genetically matched replacement cells for transplant," Egli said.

To produce the cloned embryos, the researchers used an optimised version of the laboratory technique called somatic-cell nuclear transfer (SCNT).

In the technology, the nucleus from a patient's cell is placed into an unfertilised human egg which has been stripped of its own nucleus.

This reprogrammes the cell into an embryonic state.

SCNT was the technique used to create the first mammal cloned from an adult cell - Dolly the sheep - in 1996.

The eggs were grown into early embryos.

From these, the scientists removed stem cells, which can grow into any cell type in the body.

The scientists turned these stem cells into the insulin-producing cells.

According to researchers, the breakthrough is a step toward providing perfectly genetically matched replacement cells for transplant.

In a previous research this month, researchers led by Young Gie Chung and Dong Ryul Lee at the CHA University in Seoul reported in Cell Stem Cell that they had cloned embryonic stem-cell (ES cell) lines made using nuclei from two healthy men, aged 35 and 752.

The studies show that the technique works for adult cells and in multiple labs, marking a major step.

"It's important for several reasons," said Robin Lovell-Badge, a stem-cell biologist at the MRC National Institute for Medical Research in London.

The research has been published in the journal Nature.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 29 2014 | 11:24 AM IST

Next Story